Padraig OSuilleabhain
Overview
Explore the profile of Padraig OSuilleabhain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antonini A, OSuilleabhain P, Stocchi F, Landstrom J, Waters S, Sonesson C, et al.
Mov Disord Clin Pract
. 2025 Feb;
PMID: 40008823
Background: The treatment of levodopa-induced dyskinesia in Parkinson's disease (PD) is a largely unmet need. Objectives: Mesdopetam is a novel small molecule dopamine D3 receptor antagonist aimed for the treatment...
2.
Grill N, Wainman E, Sharma V, OSuilleabhain P, Louis E
Parkinsonism Relat Disord
. 2025 Jan;
132:107291.
PMID: 39837112
Introduction: Assessing the severity of kinetic tremor is important in clinical and research settings. Archimedes spirals are often used to assess tremor severity. Rating tremor from spirals has been based...
3.
Feltrin F, White A, OSuilleabhain P, Mckenzie L, Pride L, Shah B
Mov Disord Clin Pract
. 2024 Jan;
11(4):444-446.
PMID: 38284308
No abstract available.
4.
OSuilleabhain P, Berry D, Lundervold D, Turner T, Tovar M, Louis E
Mov Disord Clin Pract
. 2023 Sep;
10(9):1317-1323.
PMID: 37772281
Background: People with essential tremor (ET) can be subject to stigma, and some adopt avoidance behaviors. Characteristics associated with ET stigma and the relationship between perceived stigma and social dysfunction...
5.
Holcomb J, Chopra R, Feltrin F, Elkurd M, El-Nazer R, Mckenzie L, et al.
Brain Commun
. 2023 Aug;
5(4):fcad165.
PMID: 37533544
MRI-guided high-intensity focused ultrasound thalamotomy is an incisionless therapy for essential tremor. To reduce adverse effects, the field has migrated to treating at 2 mm above the anterior commissure-posterior commissure...
6.
OSuilleabhain P, Tovar M, Wagle Shukla A, Tester N, Lundervold D, Turner T, et al.
Parkinsonism Relat Disord
. 2022 Oct;
104:38-43.
PMID: 36215750
Introduction: People with essential tremor commonly experience psychological difficulties that are not addressed. The effect of stigma, i.e., negative judgement by others because of a perceived difference in this case...
7.
8.
Brownstein M, Simon N, Long J, Yankey J, Maibach H, Cudkowicz M, et al.
J Clin Med
. 2020 Nov;
9(11).
PMID: 33207828
SRX246 is a vasopressin (AVP) 1a receptor antagonist that crosses the blood-brain barrier. It reduced impulsive aggression, fear, depression and anxiety in animal models, blocked the actions of intranasal AVP...
9.
Boxer A, Qureshi I, Ahlijanian M, Grundman M, Golbe L, Litvan I, et al.
Lancet Neurol
. 2019 May;
18(6):549-558.
PMID: 31122495
Background: Progressive supranuclear palsy is a rare neurodegenerative disease associated with dysfunctional tau protein. BIIB092 is a humanised monoclonal antibody that binds to N-terminal tau and is thus being assessed...
10.
McGarry A, McDermott M, Kieburtz K, de Blieck E, Beal F, Marder K, et al.
Neurology
. 2016 Dec;
88(2):152-159.
PMID: 27913695
Objective: To test the hypothesis that chronic treatment of early-stage Huntington disease (HD) with high-dose coenzyme Q10 (CoQ) will slow the progressive functional decline of HD. Methods: We performed a...